Cargando…

Prostate-Derived ETS Factor (PDEF) Modulates Yes Associated Protein 1 (YAP1) in Prostate Cancer Cells: A Potential Cross-Talk between PDEF and Hippo Signaling

PDEF (prostate-derived ETS factor, also known as SAM-pointed domain containing ETS transcription factor (SPDEF)) is expressed in luminal epithelial cells of the prostate gland and associates with luminal phenotype. The Hippo pathway regulates cell growth/proliferation, cellular homeostasis, and orga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaiswal, Praveen Kumar, Mohajan, Suman, Koul, Sweaty, Wang, Fengtian, Shi, Runhua, Koul, Hari K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958407/ https://www.ncbi.nlm.nih.gov/pubmed/31835563 http://dx.doi.org/10.3390/ph12040181

Ejemplares similares

Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF
por: Johnson, Thomas R, et al.
Publicado: (2010)

Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF
por: Johnson, Thomas R., et al.
Publicado: (2021)

Eukaryotic Translation Initiation Factor 4 Gamma 1 (eIF4G1) is upregulated during Prostate cancer progression and modulates cell growth and metastasis
por: Jaiswal, Praveen Kumar, et al.
Publicado: (2018)

Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1): a target for cancer therapeutic intervention?
por: Jaiswal, Praveen Kumar, et al.
Publicado: (2019)

AR–PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer
por: Cao, Lu, et al.
Publicado: (2018)

Mitogen Activated Protein kinase signal transduction pathways in the prostate
por: Maroni, Paul D, et al.
Publicado: (2004)

Regulation of SPDEF expression by DNA methylation in advanced prostate cancer
por: Vatanmakanian, Mousa, et al.
Publicado: (2023)

Hypoxia associated p38 Mitogen Activated Protein Kinase Mediated Androgen Receptor Activation and Increased Hif-1α Levels Contribute to emergence of an Aggressive Phenotype in Prostate Cancer
por: Khandrika, Lakshmipathi, et al.
Publicado: (2009)

Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
por: Khandrika, Lakshmipathi, et al.
Publicado: (2012)

Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
por: Singh, Vibha, et al.
Publicado: (2019)

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
por: Koinis, Filippos, et al.
Publicado: (2022)

Genome Wide Analysis of Differentially Expressed Genes in HK-2 Cells, a Line of Human Kidney Epithelial Cells in Response to Oxalate
por: Koul, Sweaty, et al.
Publicado: (2012)

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers
por: Marx, Andreas, et al.
Publicado: (2020)

Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway
por: Zeng, Hao, et al.
Publicado: (2016)

The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer
por: Cheng, Siyuan, et al.
Publicado: (2020)

SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway
por: Yang, Wenjie, et al.
Publicado: (2023)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer
por: Li, Qiji, et al.
Publicado: (2021)

The Hippo-Yes Association Protein Pathway in Liver Cancer
por: Jie, Lu, et al.
Publicado: (2013)

The Hippo Pathway in Prostate Cancer
por: Salem, Omar, et al.
Publicado: (2019)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy
por: Fodor, Lili E., et al.
Publicado: (2017)

Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome
por: Jiang, Li-Le, et al.
Publicado: (2017)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling
por: Lai, Chih-Jen, et al.
Publicado: (2019)

JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis
por: Tomlinson, V, et al.
Publicado: (2010)

Dual roles of yes-associated protein (YAP) in colorectal cancer
por: Ou, Chunlin, et al.
Publicado: (2017)

Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis
por: Sun, Zhenqiang, et al.
Publicado: (2015)

Decreased Yes-Associated Protein-1 (YAP1) Expression in Pediatric Hearts with Ventricular Septal Defects
por: Ye, Lincai, et al.
Publicado: (2015)

Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology
por: Chen, Xiaoqing, et al.
Publicado: (2020)

The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation
por: Fallah, Sepideh, et al.
Publicado: (2020)

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
por: Isfort, Ilka, et al.
Publicado: (2019)

Yes-Associated Protein Expression Is Correlated to the Differentiation of Prostate Adenocarcinoma
por: Noh, Myung-Giun, et al.
Publicado: (2017)

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
por: Reis, Leonardo O., et al.
Publicado: (2019)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

An emerging role for Hippo-YAP signaling in cardiovascular development
por: Zhou, Jiliang
Publicado: (2014)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mkvjca48semcqj1gkb6vfkpqak